TBXT and Alzheimer disease: In detail, in SH-SY5Y cells treated with Aβ 1–42 (Aβ42) oligomer/protofibril to induce AD-like neurotoxicity, both compounds reduced τ phosphorylation at Tyr18 in a dose-dependent manner.